Browse announcements from the Press Release India archive.
Legendary Cricketer Harbhajan Singh launched Amulya Mica’s Visually Perfect, 1MM Collection, called Expert’s Eye on 22nd of May 2021 in an online virtual event in association with Ply Reporter & Surfaces Reporter. The event was attended by more than 4000 & vie
L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leading pure-play engineering services company, announced that it has signed a collaboration agreement with UK’s Coventry University to build and deliver new generation engineering solutions fo
Mori Building Co., Ltd., Japan’s leading urban landscape developer, announced today that major redevelopments the company is undertaking in Tokyo have been precertified under the prestigious LEED (Leadership in Energy and Environmental Design) and WELL (WELL Bu
Interim analysis of the Phase 3 PUNCH™ CD3-Open-Label Study (OLS) showed positive efficacy and consistent safety with RBX2660 for up to six months in patients with recurrent Clostridioides difficile (C. difficile) infection, adding to robust evidence of larges
− Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalizations and 62.0% of dengue illness overall, with no identified important safety risks through three years following vaccination in ongoing pivotal Phase 3 TIDES trial − Regulatory filing
In a recent ET article published on 19th May sources at the Finance Ministry confirmed that the Government wants to regulate cryptocurrencies and take a calibrated approach in the best interest of investors and the ecosystem. This comes like a relief to some e
RBX2660 pivotal Phase 3 trial successfully met the primary endpoint; data presented today at Digestive Disease Week® (DDW) RBX2660 is the first microbiota-based live biotherapeutic to demonstrate efficacy as early as first recurrence of Clostridioides difficil
New analyses from pivotal BAVENCIO® study reinforce unique clinical benefits across different subgroups in the treatment of advanced urothelial carcinoma New data from VISION study of TEPMETKO® show association between liquid biopsy-identified biomarker and cl
- The positive opinion is based on the EMPEROR-Reduced trial, which showed a significant 25 percent reduction in the combined relative risk of cardiovascular death or hospitalization for heart failure - The results were observed in adults with heart failure wi
River damming, water pollution, overfishing, and sand quarrying have been damaging the living environment of aquatic organisms in the Yangtze River for some time. The decline of biodiversity in the Yangtze ecosystem is an immediate threat to fishery production,
End-to-end 5G Private Network with Open RAN capabilities, cloud-enabled 5G Core, orchestration and analytics, and an ecosystem of device and application partners Ban Chang ‘Silicon Beach’ Smart City showcasing today’s technology in partnership with 5GCT, Maven
− The Ministry of Health, Labour and Welfare (MHLW) Grants Regulatory Approval of Moderna’s COVID-19 Vaccine (COVID-19 Vaccine Moderna Intramuscular Injection) Following Positive Interim Results in Takeda’s Phase 1/2 Immunogenicity and Safety Clinical Trial − I
− If Approved, Maribavir Will Be the First and Only Treatment Indicated for Post-Transplant Cytomegalovirus (CMV) Infection in Those That Are Refractory, With or Without Resistance (R/R) − NDA based on Phase 3 Trial of Maribavir Which Met Its Primary Endpoint
What started out as a way for the style community to come together when the pandemic stopped the industry in its tracks has grown into one of the largest gatherings of the fashion industry worldwide. Now, with life opening back up in the US and abroad, Glamhive
Schlumberger announced today a collaboration with Amazon Web Services (AWS) to deploy domain centric digital solutions, enabled by the DELFI* cognitive E&P environment, on the cloud with AWS. This collaboration will bring AWS customers to the DELFI Petrotechnic